NCT04072497View on ClinicalTrials.gov

A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

522

Participants

Timeline

Start Date

November 20, 2018

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Herpes Zoster
Interventions
BIOLOGICAL

One shot of the zoster vaccine

One shot of the zoster vaccine (with live virus \>=4.3 LgPFU per dose)

BIOLOGICAL

One shot of the varicella vaccine

One shot of the varicella vaccine (with live virus \>=3.3 LgPFU per dose)

BIOLOGICAL

one shot of placebo

one shot of placebo with no live virus

Trial Locations (1)

450016

Henan Provincial Center for Disease Control and Prevention, Zhaoge

All Listed Sponsors
lead

Shanghai Institute Of Biological Products

INDUSTRY

NCT04072497 - A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years | Biotech Hunter | Biotech Hunter